Martin Dossenbach, MD
- 4Articles
- 12.7KReads
- 2004–2008Active
- 37Collaborators
- 82Citations
About
Martin Dossenbach, MD, has contributed to research on schizophrenia and schizoaffective disorders, with a focus on antipsychotic monotherapy and treatment outcomes. His work includes observational studies comparing the effectiveness and relapse rates associated with olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach has also explored somatoform disorders and the impact of painful physical symptoms in major depressive disorder. His publications span from 2004 to 2008 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
